| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |